![Kyle Dempsey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kyle Dempsey
Directeur/Bestuurslid bij
HLS THERAPEUTICS INC.
Vermogen: 5 798 $ op 31-05-2026
Profiel
Kyle Dempsey currently works at GT Medical Technologies, Inc., as Director, HLS Therapeutics, Inc., as Independent Director from 2022, MVM Partners LLP, as Partner, and MVM Partners LLC, as Partner from 2017.
Dr. Dempsey also formerly worked at OptiNose, Inc., as Independent Director from 2021 to 2025.
Dr. Dempsey received his undergraduate degree from Bowdoin College, doctorate degree from Harvard Medical School, and Masters Business Admin degree from Harvard Business School.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-03-2026 | 1.765 ( 0,01% ) | 5 798 $ | 31-05-2026 |
Actieve functies van Kyle Dempsey
| Bedrijven | Functie | Begin |
|---|---|---|
| HLS THERAPEUTICS INC. | Directeur/Bestuurslid | 29-11-2022 |
MVM Partners LLC
 MVM Partners LLC Investment ManagersFinance Functions as an alternative investment manager | Private Equity Investor | 01-09-2017 |
GT Medical Technologies, Inc.
 GT Medical Technologies, Inc. Medical SpecialtiesHealth Technology Develops and manufactures medical equipment for the treatment of brain tumors | Directeur/Bestuurslid | - |
MVM Partners LLP
 MVM Partners LLP Investment ManagersFinance MVM Partners invests in companies located across the globe. The firm focuses on healthcare and life sciences sectors. It provides financing for growth capital requirements with an investment size of USD 20 - 100 million. | Private Equity Investor | - |
Eerdere bekende functies van Kyle Dempsey
| Bedrijven | Functie | Einde |
|---|---|---|
| OPTINOSE, INC. | Directeur/Bestuurslid | 21-05-2025 |
Opleiding van Kyle Dempsey
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
11
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
OptiNose, Inc.
 OptiNose, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes products for patients treated by ear, nose, throat and allergy diseases | Health Technology |
MVM Partners LLP
MVM Partners LLP Investment ManagersFinance MVM Partners invests in companies located across the globe. The firm focuses on healthcare and life sciences sectors. It provides financing for growth capital requirements with an investment size of USD 20 - 100 million. | Finance |
Bowdoin College
 Bowdoin College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MVM Partners LLC
MVM Partners LLC Investment ManagersFinance Functions as an alternative investment manager | Finance |
GT Medical Technologies, Inc.
GT Medical Technologies, Inc. Medical SpecialtiesHealth Technology Develops and manufactures medical equipment for the treatment of brain tumors | Health Technology |
HLS Therapeutics, Inc.
 HLS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
